Cargando…
Screening for an ivermectin slow-release formulation suitable for malaria vector control
BACKGROUND: The prospect of eliminating malaria is challenged by emerging insecticide resistance and vectors with outdoor and/or crepuscular activity. Ivermectin can simultaneously tackle these issues by killing mosquitoes feeding on treated animals and humans. A single oral dose, however, confers o...
Autores principales: | Chaccour, Carlos, Barrio, Ángel Irigoyen, Royo, Ana Gloria Gil, Urbistondo, Diego Martinez, Slater, Hannah, Hammann, Felix, Del Pozo, Jose Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355127/ https://www.ncbi.nlm.nih.gov/pubmed/25872986 http://dx.doi.org/10.1186/s12936-015-0618-2 |
Ejemplares similares
-
Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation
por: Chaccour, Carlos J., et al.
Publicado: (2018) -
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
por: Chaccour, Carlos, et al.
Publicado: (2020) -
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae
por: Chaccour, Carlos J., et al.
Publicado: (2017) -
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
por: Chaccour, Carlos, et al.
Publicado: (2020)